The PBM industry emerged in response to a wave of expensive new blockbuster drugs that began to come to market in the 1990s. Before then, very few patients had “pharmacy benefits.” Today, a patient with insurance coverage may pay a mere $10 copay for a drug that costs 10 times that much.
Government Solution Not Needed to Reduce Drug Costs
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such